» Articles » PMID: 37985893

Klotho Inhibits IGF1R/PI3K/AKT Signalling Pathway and Protects the Heart from Oxidative Stress During Ischemia/reperfusion Injury

Overview
Journal Sci Rep
Specialty Science
Date 2023 Nov 21
PMID 37985893
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemia/reperfusion injury (IRI) of the heart involves the activation of oxidative and proapoptotic pathways. Simultaneously Klotho protein presents anti-aging, antiapoptotic and antioxidative properties. Therefore, this study aimed to evaluate the effect of Klotho protein on oxidative stress in hearts subjected to IRI. Isolated rat hearts perfused with the Langendorff method were subjected to ischemia, followed by reperfusion, in the presence or absence of recombinant rat Klotho protein. The factors involved in the activation of insulin-like growth factor receptor (IGF1R)/phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) signalling pathway were evaluated. IRI caused activation of the IGF1R (p = 0.0122)/PI3K (p = 0.0022) signalling, as compared to the aerobic control group. Infusion supply of Klotho protein during IRI significantly reduced the level of phospho-IGF1R (p = 0.0436), PI3K (p = 0.0218) and phospho-AKT (p = 0.0020). Transcriptional activity of forkhead box protein O3 (FOXO3) was reduced (p = 0.0207) in hearts subjected to IRI, compared to aerobic control. Administration of Klotho decreased phosphorylation of FOXO3 (p = 0.0355), and enhanced activity of glutathione peroxidase (p = 0.0452) and superoxide dismutase (p = 0.0060) in IRI + Klotho group. The levels of reactive oxygen/nitrogen species (ROS/RNS) (p = 0.0480) and hydrogen peroxide (HO) (p = 0.0460), and heart injury (p = 0.0005) were significantly increased in hearts from the IRI group in comparison to the aerobic group. Klotho reduced NADPH oxidase 2 (NOX2) (p = 0.0390), ROS/RNS (p = 0.0435) and HO (p = 0.0392) levels, and heart damage (p = 0.0286) in the hearts subjected to IRI. In conclusion, Klotho contributed to the protection of the heart against IRI and oxidative stress via inhibition of the IGF1R/PI3K/AKT pathway, thus can be recognized as a novel cardiopreventive/cardioprotective agent.

Citing Articles

Elucidating the pharmacological foundations and mechanisms of the Sihai Shuyu formula in treating Graves' disease through integrated serum metabolomics and network pharmacology with molecular docking techniques.

Liu X, Li X, Huang W, Cui Y, Cheng F, Chen G Front Endocrinol (Lausanne). 2025; 16:1511808.

PMID: 39950029 PMC: 11821505. DOI: 10.3389/fendo.2025.1511808.


Sex differences in the association between serum α-Klotho levels and hyperlipidemia: a cross-sectional study from NHANES 2013-2016.

Han Y, Liu C, Nie Y, Jiang X, An N, Qin Y Sci Rep. 2025; 15(1):4919.

PMID: 39929854 PMC: 11811052. DOI: 10.1038/s41598-024-85018-3.


Molecular and Cellular Mechanisms of Immunosenescence: Modulation Through Interventions and Lifestyle Changes.

Pangrazzi L, Meryk A Biology (Basel). 2025; 14(1).

PMID: 39857248 PMC: 11760833. DOI: 10.3390/biology14010017.


Association between serum Klotho and the prevalence of osteoarthritis: A cross-sectional study from NHANES 2007-2016.

Qiu Y, Yin H, Meng J, Cai Y, Huang J, Zheng X PLoS One. 2024; 19(11):e0312562.

PMID: 39556550 PMC: 11573205. DOI: 10.1371/journal.pone.0312562.


Distinct role of Klotho in long bone and craniofacial bone: skeletal development, repair and regeneration.

Chen X, Wei Y, Li Z, Zhou C, Fan Y PeerJ. 2024; 12:e18269.

PMID: 39465174 PMC: 11505971. DOI: 10.7717/peerj.18269.


References
1.
Yu T, Li L, Liu W, Ya B, Cheng H, Xin Q . Silencing of NADPH Oxidase 4 Attenuates Hypoxia Resistance in Neuroblastoma Cells SH-SY5Y by Inhibiting PI3K/Akt-Dependent Glycolysis. Oncol Res. 2018; 27(5):525-532. PMC: 7848326. DOI: 10.3727/096504018X15179668157803. View

2.
Chen L, Liu P, Feng X, Ma C . Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo. J Cell Mol Med. 2017; 21(12):3178-3189. PMC: 5706507. DOI: 10.1111/jcmm.12871. View

3.
Takenaka T, Kobori H, Inoue T, Miyazaki T, Suzuki H, Nishiyama A . Klotho supplementation ameliorates blood pressure and renal function in DBA/2-pcy mice, a model of polycystic kidney disease. Am J Physiol Renal Physiol. 2020; 318(3):F557-F564. DOI: 10.1152/ajprenal.00299.2019. View

4.
Taneike M, Nishida M, Nakanishi K, Sera F, Kioka H, Yamamoto R . Alpha-Klotho is a novel predictor of treatment responsiveness in patients with heart failure. Sci Rep. 2021; 11(1):2058. PMC: 7820312. DOI: 10.1038/s41598-021-81517-9. View

5.
Hsu C, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N . Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation. 2010; 122(21):2170-82. PMC: 3003297. DOI: 10.1161/CIRCULATIONAHA.110.958033. View